Expression and Significance of PI-PLCε1 in Colon Cancer

LI Xiao-ran, YANG Kun, HUANG Xiao-li

Abstract

To study the expression and clinical significance of phosphoinositide-specific phospholipase Cε1 (PI-PLCε1) in the pathogenesis of colon cancer. MethodsqRT-PCR and immunohistochemistry were used to detect the expression of PI-PLCε1in the 42 cases of colon cancer tissues and their corresponding adjacent tissues. And the effects of tumor differentiation and tumor site on the expression PI-PLCε1 of colon cancer tissues were compared. ResultsThe results of qRT-PCR showed that the expression of PI-PLCε1in colon cancer tissue significantly lower than that in the adjacent tissue ( P<0.05). The expression of PI-PLCε1gene of colon cancer tissue was not effected by tumor differentiation and tumor site ( P>0.05). The results of immuno-histochemistry showed that the positive expression rate of PI-PLCε1 protein in colon cancer tissue was significantly lower than that in the adjacent tissue ( P<0.05). The positive expression rate of PI-PLCε1 protein was not effected by tumor differentiation ( P>0.05), but the expression was different in tumor site ( P<0.05). Conclusion Expression of PI-PLCε1 was reduced in colon tissue and barely to tumor differentiation.

 

Keywords: Colon cancer, PI-PLCε1qRT-PC, RImmunohistochemistry 

 

Full Text:

PDF


References


SHI Z, CHEN H, LIAN Z, et al. Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder; anxiety, disability, fatigue and depression. J Neuroimmunol. 2016, 293; 54-58 [2016-04-15 . https ://dx. doi. org/10. 1016/j. jneuroim. 2016. 02. 011.

WINGERCHUK DM, LENNON VA, PITTOCK SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology,2006,66( 10): 1485-1489.

HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol, 1959,32(l):50-55.

HAMILTON M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol, 1967 , 6 ( 4 ): 278- 296.

MILLER A, DISHON S. Health-related quality of life in multiple sclerosis; the impact of disability, gender and employment status. Qual Life Res,2006,15(2);259-271.

KANAMORI Y, NAKASHIMA I, TAKAI Y, et al. Pain in neuromyelitis optica and its effect on quality of life; a cross- sectional study. Neurology,2011,77(7); 652-658.

KIM SM, GO MJ, SUNG JJ, et al. Painful tonic spasm in neuromyelitis optica; incidence, diagnostic utility, and clinical characteristics. Arch Neurol,2012,69(8); 1026-1031.

QIAN P, LANCIA S, ALVAREZ E, et al. Association of neuromyelitis optica with severe and intractable pain. Arch Neurol,2012,69( 11): 1482-1487.

ZHAO S, MUTCH K, ELSONE U et al. Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life. Mult Scler,2014 ,20( 12); 1658-1661.

KALIA LV, O'CONNOR PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler.2005» 11(3):322-327.

BRUCE JM, ARNETT P. Clinical correlates of generalized worry in multiple sclerosis. J Clin Exp Neuropsychol, 2009, 31(6) ;698-705.

NEWLANDPK. FEARING A, RILEY M, etui. Symptom clusters in women with relapsing-remitting multiple sclerosis. J Neurosci Nurs,2012»44(2):66-71.

BRADL M, KANAMORI Y. NAKASHIMA Uetal. Pain in neuromyelitis optica prevalence, pathogenesis and therapy. Nat Rev Neurol.2014 ,10(9);529-536.

NAQVI F. CERVO F. Fields S. Evidence-based review of interventions to improve palliation of pain, dyspnea, depression. Geriatrics,2009,64(8);8-10, 12-14.

ABNETCC, FREEDMAN ND, HU N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet, 2010,42(9):764-767.

KELLEY GG, REKS SE. ONDRAKO JM, et al. Phospholipase Ce:a novel Ras effector. EM BO J, 2001, 20 (4):743-754.

BUNNEYTD, HARRIS R. GANDARILLAS NL, et al. Structural and mechanistic insights into ras association domains of phospholipase С epsilon. Mol Cell, 2006, 21 ( 4 ): 495-507.

WING MR, BOURDON DM. HARDEN TK. PLC-e, a shared effector protein in Ras-, Rho-, and Ga{3y-mediated signaling. Mol Interv,2003,3(5) :273-280

SONG С, HU CD. MASAGO M, et al. Regulation of a novel human phospholipase C, PLCe, through membrane targeting by Ras. J Biol Chem.2001,276(4) :2752-2757.

WANG LD. ZHOU FY. LI XM. et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet,2010.42(9) :759-763.

WU C, HU Z, HE Z, el al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet , 2011*43(7):679-681.

CHEN J, WANG W, ZHANG T, et al. Differential expression of phospholipase С epsilon 1 is associated with chronic atrophic gastritis and gastric cancer. PLoS One, 2012.7(10):e47563[2016-02-12]. https://doi. org/10. 1371/ journal, pone. 0047563.

WANG Q. CHEN P, CHEN D, et al. Association between phospholipase С epsilon gene (PLCE1) polymorphism and colorectal cancer risk in a Chinese population. J Int Med Res, 2014,42(2):270-281,

LI M, EDAMATSU H, KITAZAWA R, et al. Phospholipase Ce promotes intestinal tumorigenesis of ApcMin/+ mice through augmentation of inflammation and angiogenesis. Carcinogenesis,2009 ,30(8): 1424-1432.


Refbacks

  • There are currently no refbacks.